C4 Therapeutics
CCCC
$6.74
Share price
4.82%
Change (1 day)
114.65%
Change (1 year)
Categories
P/S ratio for C4 Therapeutics (CCCC)
P/S ratio as of May 2024 (TTM): 21.3
According to C4 Therapeutics's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 21.2518. At the end of 2023 the company had a P/S ratio of 13.4.
P/S ratio history for C4 Therapeutics from 2020 to 2023
PS ratio at the end of each year
| Year | P/S ratio | Change |
|---|---|---|
| 2023 | 13.4 | 44.42% |
| 2022 | 9.29 | -72.84% |
| 2021 | 34.2 | -20.37% |
| 2020 | 42.9 |
P/S ratio for similar companies or competitors
| Company | P/S ratio | P/S ratio differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | N/A | N/A | 🇺🇸 USA |